Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bright Minds Biosciences Inc DRUG


Primary Symbol: C.DRUG

Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (CSE:DRUG)

No current opinion is available.

Bullboard Posts (CSE:DRUG)

DRUG...it's all about the money Honey

Huge waterfall after the "blowoff"....when the P.O announcement???? Sheeeesh !!!!!!!!!!!!!!!
Iseneschal - August 8, 2023

DRUG ....scalped

on the move
Iseneschal - July 17, 2023

DRUG.... Bleeding like a stuffed pig

What else Go do some more drugs ; )
Iseneschal - July 14, 2023

DRUG ..... 5 : 1 RS this a.m

Let it bleed
Iseneschal - July 14, 2023

There’s been a lot of buzz about psychedelic stocks lately

 DRUG has actually kept the gains it made on its mid-August sympathy run.   The psychedelic sector hasn’t caught fire...
OTCLegenda - September 19, 2022

Bright Minds Begins Phase 1 Clinical Trials Focused On Treat

Phase 1 trials are officially underway for Bright Minds Biosciences and their lead product, referred to as BMB-101. The firm this...
AwareInvestor - August 31, 2022